Mercer Global Advisors
BMY icon

Mercer Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Mercer Global Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.7M Buy
588,491
+127,574
+28% +$7.44M 0.05% 222
2025
Q4 		$23.9M Buy
460,917
+172,632
+60% +$8.3M 0.04% 294
2025
Q3 		$13M Buy
288,285
+41,405
+17% +$1.93M 0.02% 404
2025
Q2 		$11.4M Sell
246,880
-18,494
-7% -$908K 0.02% 358
2025
Q1 		$16.2M Buy
265,374
+1,095
+0.4% +$63.8K 0.04% 266
2024
Q4 		$14.9M Sell
264,279
-109,473
-29% -$6.12M 0.04% 271
2024
Q3 		$19.7M Sell
373,752
-8,396
-2% -$394K 0.05% 210
2024
Q2 		$12.5M Sell
382,148
-228,726
-37% -$10.2M 0.03% 265
2024
Q1 		$33.1M Buy
610,874
+143,127
+31% +$7.29M 0.09% 144
2023
Q4 		$24M Buy
467,747
+1,082
+0.2% +$56.8K 0.07% 171
2023
Q3 		$27.1M Sell
466,665
-17,802
-4% -$1.09M 0.1% 125
2023
Q2 		$31M Sell
484,467
-695
-0.1% -$46.6K 0.12% 116
2023
Q1 		$33.6M Buy
485,162
+74,427
+18% +$5.25M 0.15% 101
2022
Q4 		$29.6M Buy
410,735
+104,541
+34% +$7.88M 0.15% 107
2022
Q3 		$21.8M Buy
306,194
+33,099
+12% +$2.4M 0.13% 127
2022
Q2 		$21M Buy
273,095
+31,380
+13% +$2.39M 0.13% 124
2022
Q1 		$17.7M Buy
241,715
+118,989
+97% +$7.99M 0.1% 151
2021
Q4 		$7.65M Sell
122,726
-788
-0.6% -$46.2K 0.05% 286
2021
Q3 		$7.31M Buy
123,514
+9,272
+8% +$611K 0.05% 276
2021
Q2 		$7.63M Buy
114,242
+9,420
+9% +$614K 0.06% 254
2021
Q1 		$6.62M Sell
104,822
-30,835
-23% -$1.92M 0.06% 255
2020
Q4 		$8.41M Buy
135,657
+5,057
+4% +$311K 0.11% 147
2020
Q3 		$7.87M Buy
130,600
+21,365
+20% +$1.29M 0.12% 130
2020
Q2 		$6.42M Buy
109,235
+21,099
+24% +$1.26M 0.12% 129
2020
Q1 		$4.91M Buy
88,136
+39,149
+80% +$2.39M 0.11% 160
2019
Q4 		$3.14M Buy
48,987
+6,015
+14% +$344K 0.06% 248
2019
Q3 		$2.18M Buy
42,972
+2,225
+5% +$105K 0.05% 289
2019
Q2 		$1.85M Buy
40,747
+4,554
+13% +$212K 0.05% 303
2019
Q1 		$1.73M Buy
+36,193
New +$1.8M 0.06% 272

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mercer Global Advisors's BMY Position: Q1 2026 in Review

Mercer Global Advisors increased its Bristol-Myers Squibb (BMY) stake by 28% in Q1 2026, buying an estimated $7.44M and bringing the position to 588,491 shares worth $35.7M. The position accounts for 0.05% of the portfolio, ranked #222.

Mercer Global Advisors first reported a position in BMY in Q1 2019 and has held it in 29 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mercer Global Advisors held 588,491 shares of Bristol-Myers Squibb worth $35.7M as of Q1 2026.
  • Mercer Global Advisors bought 127,574 Bristol-Myers Squibb shares in Q1 2026, an estimated $7.44M.
  • Bristol-Myers Squibb made up 0.05% of Mercer Global Advisors's portfolio in Q1 2026, its #222 holding.
  • Mercer Global Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 29 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.